Novartis buys GSK business for up to $16bn in restructuring – Financial Times

Financial Times
Novartis and GlaxoSmithKline have agreed to swap a series of assets in a multibillion-dollar deal that will reshape two of the world’s biggest drugmakers. GSK will sell its portfolio of cancer drugs to Novartis for up to $16bn and buy the Swiss group’s vaccines …
Lilly Announces Agreement to Acquire Novartis Animal HealthMarketWatch
GSK shuns talk of mega-mergers as it unveils ‘complex’ Novartis dealTelegraph.co.uk
Novartis, GlaxoSmithKline Consumer-Health Business Unites Big BrandsWall Street Journal
The Globe and MailEconomic TimesWISH
all 214 news articles

…read more

Source: Business News From Google News

Leave a Comment